Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Bank of America downgraded Quest Diagnostics (NYSE: DGX) from “buy” to “underperform.” The target price for Quest Diagnostics has been lowered from $64 to $55. Quest Diagnostics' shares closed at $60.33 yesterday.

Morgan Stanley downgraded Home Properties (NYSE: HME) from “equal-weight” to “underweight.” The target price for Home Properties has been lowered from $67 to $59. Home Properties' shares closed at $55.33 yesterday.

Analysts at RBC Capital downgraded Tenneco Automotive (NYSE: TEN) from “top pick” to “outperform.” The target price for Tenneco Automotive is set to $66. Tenneco Automotive's shares closed at $56.27 yesterday.

Wells Fargo downgraded Edwards Lifesciences (NYSE: EW) from “outperform” to “market perform.” Edwards Lifesciences' shares closed at $62.73 yesterday.

Latest Ratings for DGX

DateFirmActionFromTo
Oct 2019MaintainsNeutral
Aug 2019MaintainsOverweight
Jul 2019MaintainsNeutral

View More Analyst Ratings for DGX
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (DGX + EW)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MDStifelUpgrades33.0
CATStandpoint ResearchDowngrades
LULUPiperJaffrayMaintains245.0
LULUWells FargoMaintains260.0
TREEOppenheimerMaintains380.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Top #PreMarket Gainers

Benzinga's Top Upgrades